Parathymosin (PTMS) as A Drug Target and Biomarker for Diseases

Target Name: PTMS

NCBI ID: G5763

PTMS

Parathymosin (PTMS) as A Drug Target and Biomarker for Diseases

Parathymosin (PTMS) is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and pancreas. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells.

One of the unique features of PTMS is its ability to interact with dystrophin, a protein that is involved in the development and maintenance of muscle mass and tissue repair. This interaction between PTMS and dystrophin has led to the potential use of PTMS as a drug target or biomarker for a variety of diseases.

PTMS has been shown to play a role in the regulation of muscle growth and maintenance, as well as in the development and progression of certain diseases. For example, studies have shown that increased levels of PTMS can promote muscle growth and improve muscle function in individuals with muscular dystrophy. Additionally, higher levels of PTMS have been associated with the development of certain diseases, such as heart failure and cancer.

As a drug target, PTMS has the potential to treat a variety of conditions that are related to the regulation of muscle mass and tissue repair. For example, PTMS has been shown to be involved in the development of muscle weakness and muscle wasting in individuals with certain genetic disorders, such as muscular dystrophy. Additionally, PTMS has been shown to play a role in the regulation of cellular signaling pathways, which can lead to the development of certain diseases, such as cancer.

As a biomarker, PTMS has the potential to be used as a diagnostic tool for certain diseases. For example, PTMS has been shown to be involved in the regulation of muscle mass and function in individuals with certain genetic disorders, such as muscular dystrophy. Additionally, PTMS has been shown to be involved in the regulation of cellular signaling pathways, which can lead to the development of certain diseases, such as cancer.

In conclusion, Parathymosin (PTMS) is a protein that is expressed in various tissues throughout the body that is involved in the regulation of muscle mass and tissue repair. Its ability to interact with dystrophin and its involvement in the regulation of cellular signaling pathways make it a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of PTMS in these processes and to develop effective treatments for the associated conditions.

Protein Name: Parathymosin

Functions: Parathymosin may mediate immune function by blocking the effect of prothymosin alpha which confers resistance to certain opportunistic infections

The "PTMS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PTMS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets